A respected veteran with nearly 25 years in the clinical research services industry, John Potthoff, Ph.D., has directed major business for a number of companies. Currently CEO of Elligo Health Research, Potthoff leads a company that expands access to clinical research by bringing together health care data, community physicians and their patients.
Potthoff’s career began with a series of executive roles involving increasing responsibility at PPD. He later was founder and CEO of Tanistry, Inc., a contract research organization focused on the central nervous system that he sold in 2001 to INC Research where he later became COO. In 2011, Potthoff became CEO at Theorem Clinical Research and doubled its revenue, sales, backlog and earnings in four years before the company was sold to Chiltern. Potthoff is currently on the board of directors of Advarra, Chembio and Synteract.